Physician profile
Michael Lam
NPI 1184656050
$1,075.15
in general payments reported to CMS, 2019-2025
8 companies · $32.77 in 2025
The $32.77 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $34.58 · 2021: $11.40 · 2022: $366 · 2023: $256 · 2024: $125 · 2025: $32.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $364.69 | 2022-2024 | |
| Merz North America, INC. | $288.47 | 2023-2025 | Xeomin |
| Janssen Pharmaceuticals, INC | $124.99 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $124.29 | 2019 | |
| Gilead Sciences, INC. | $89.76 | 2022 | |
| Advanced Respiratory, INC | $34.58 | 2020 | |
| Allergan, INC. | $26.57 | 2021-2022 | |
| Acelrx Pharmaceuticals, INC. | $21.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.